Beijing Hotgen Biotech Co., Ltd.
Exhibitors
Information
Beijing Hotgen Biotech Co., Ltd. (“Hotgen Biotech”), founded in 2005, is a high-tech enterprise specializing in the biopharmaceutical field. The company was listed on the STAR Market of the Shanghai Stock Exchange in September 2019 (Stock Code: 688068).
Hotgen Biotech has established eight major technology platforms, including bioactive raw material development, GlyExo-Capture®, chemiluminescence immunoassay, up-converting phosphor technology, colloidal gold immunochromatography, Enzyme-Linked ImmunoSorbent Assay, molecular diagnostics, and instrument development.
Our product portfolio spans the full spectrum of immunodiagnostics — from high-precision Up-Conversion POCT (UPT series) to compact, mid-sized, and fully automated single-test chemiluminescence analyzers (MQ60 series), and high-throughput automated chemiluminescence platforms (C800).
Hotgen Biotech’s products have obtained certificates and registrations from major regulatory authorities worldwide, with over 600 international qualifications to date — among them, more than 90 CE IVDR certificates. we are committed to providing better services to our global customers and continuously expanding our international presence.
